Pharmacokinetic studies determined

Pharmacokinetic studies are designed to measure quantitatively the rate of uptake and metaboHsm of a material and determine the absorbed dose to determine the distribution of absorbed material and its metaboHtes among body fluids and tissues, and their rate of accumulation and efflux from the tissues and body fluids to determine the routes and relative rates of excretion of test material and metaboHtes and to determine the potential for binding to macromolecular and ceUular stmctures. 

Absorption, Distribution, Metabolism, and Excretion. There are no data available on the absorption, distribution, metabolism, or excretion of diisopropyl methylphosphonate in humans. Limited animal data suggest that diisopropyl methylphosphonate is absorbed following oral and dermal exposure. Fat tissues do not appear to concentrate diisopropyl methylphosphonate or its metabolites to any significant extent. Nearly complete metabolism of diisopropyl methylphosphonate can be inferred based on the identification and quantification of its urinary metabolites however, at high doses the metabolism of diisopropyl methylphosphonate appears to be saturated. Animal studies have indicated that the urine is the principal excretory route for removal of diisopropyl methylphosphonate after oral and dermal administration. Because in most of the animal toxicity studies administration of diisopropyl methylphosphonate is in food, a pharmacokinetic study with the compound in food would be especially useful. It could help determine if the metabolism of diisopropyl methylphosphonate becomes saturated when given in the diet and if the levels of saturation are similar to those that result in significant adverse effects. 

There are special problems in bioequivalency determinations when conventional pharmacokinetic studies are not possible. For example, when drugs are administered intranasally for direct treatment of receptors in the nasal mucosa, the concentration of drug in plasma may be below the limit of quantification. In such cases we are forced to attempt measurement of clinical response. The subjectivity and/or low precision of this type of study can be a serious problem. 

Kobylinska et al. [62] described a high performance liquid chromatographic analytical method for the determination of miconazole in human plasma using solid-phase extraction. The method uses a solid-phase extraction as the sample preparation step. The assay procedure is sensitive enough to measure concentrations of miconazole for 8 h in a pharmacokinetic study of Mikonazol tablets and Daktarin tablets in human volunteers. The pharmacokinetics of the two formulations was equivalent. 

Phenothiazines (acepromazine, propio-promazine, promazine, trimepra-zine, methotrimeprazine, thioridazine, chlorpromazine) 7.5-64,000 2.2-66.5 1.0-3.7 Acepromazine was determined in horse plasma with good results the method is suitable for pharmacokinetic studies 43... 

Ma, Y. et al. 2007. Determination and pharmacokinetic study of amlodipine in human plasma by ultra performance liquid chromatography-electrospray ionization mass spectrometry. J Pharm Biomed Anal. 43 1540. 

A recent study determined the myocardium to plasma concentration ratios of five antipsychotics and underscored the importance of interpreting hERG channel and electrophysiological data in conjunction with other pharmacokinetic parameters [114]. 

The permeability of the drug substance can be determined by different approaches such as pharmacokinetic studies in humans (fraction absorbed or mass balance studies) or intestinal permeability studies (in vivo intestinal perfusion studies in humans or suitable animal models or in vitro permeation studies using excised intestinal tissue or epithelial cell culture monolayers like CaCo-2 cell line). In order to avoid misclassification of a drug subject to efflux transporters such as P-glycoprotein, functional expression of such proteins should be investigated. Low- and high-permeability model... 

Li, L., Sheng, Y., Zhang, J., Wang, C., and Guo, D.-A. (2004a). HPLC determination of four active saponins from Panax notoginseng in rat serum and its application to pharmacokinetic studies. Biomed. Chromatogr. 18,849-856. 

Srinivas NR, Shyu WC, Barbhaiya RH. 1995. Gas chromatographic determination of enantiomers as diastereo-mers following pre-column derivatization and applications to pharmacokinetic studies a review. Biomed Chromatogr 9 1. 

The study of ADME had its origins in pharmacology, the science of drugs. Because these processes involve rates of different types, this area of study came to be called pharmacokinetics The combined effects of these pharmacokinetic processes determine the concentration a particular chemical (the chemical entering the body or one or more of its metabolites) will achieve in various tissues and cells of the... 

Comparative Toxicokinetics. Pharmacokinetics studies have not been performed under conditions analogous to those of the carcinogenicity studies. Therefore, it is not possible to determine systemic levels of the compound associated with the reported effects. Pharmacokinetics data developed under exposure conditions associated with biological effects would markedly increase the possibility of improved species extrapolation for evaluating the true potency of 3,3 -dichlorobenzidine. 

Besides the poor specificity of many of the assays used to determine plasma drug concentrations, another problem which has arisen from these studies has been the length of the "wash-out" period necessary before the patient is given the neuroleptic under investigation. As a result of the prolonged duration of blockade of dopamine receptors in the brain by conventional neuroleptics and their metabolites, it is necessary to allow a wash-out period of several weeks before the patients are subject to a pharmacokinetic study. This raises serious ethical questions. Perhaps with the advent of new imaging techniques it may be possible in the near future actually to determine the rate of disappearance of neuroleptics from the brain of the patient. This may enable the relationship between plasma concentration and clinical response to be accurately determined. 

Gu R, Don G Wang J, Dong J, Meng Z. (2007) Simultaneous determination of 1,5-dicaffeoylquinic acid and its active metabolites in human plasma by liquid chromatography-tandem mass spectrometry for pharmacokinetic studies. J Chromatogr B 852 85-91. 

First, they can be used to generate hypotheses. Because of their nature when data are extracted from the literature across diverse study protocols meta-analyses can be extremely useful in generating h)rpotheses particularly concerning subgroups of patients. In this sense their use mirrors one potential objective of a population pharmacokinetic study that may be to determine interesting covaiiates, which influence drug... 

Pharmacokinetic studies have not determined whether TCTFE is metabolized by humans or eliminated unchanged. ... 

---